多族裔细胞因子谱揭示多囊卵巢综合征存在免疫失调而非慢性炎症
结果显示PCOS患者多种免疫标志物水平显著降低(P<.05),包括生长因子、促炎细胞因子和趋化因子,且独立于种族;仅IL-18和CXCL16在黑人与白人女性间有显著差异。结论挑战了PCOS为慢性低度炎症的 prevailing 观点,提示免疫抑制和血管生成信号受损可能参与PCOS病理生理,尤其在非肥胖患者中。
要点
- PCOS患者多种循环免疫标志物水平显著降低,而非升高。
- 生长因子、促炎细胞因子和趋化因子在PCOS中普遍降低,独立于种族。
- 仅IL-18和CXCL16在Black与White女性间存在显著差异。
核心结论
- PCOS患者表现为免疫标志物普遍降低,提示免疫失调而非慢性低度炎症。
- 免疫抑制和血管生成信号受损可能是PCOS病理生理因素,尤其在非肥胖患者中。
- 研究结果需更大样本和代谢指标验证后才能应用于临床实践。
研究设计与样本
- 回顾性横断面研究,样本来自Androgen Excess Biorepository于1987至2010年间采集。
- 受试者来自阿拉巴马大学伯明翰分校和Cedars-Sinai医学中心的生殖内分泌门诊。
主要发现
- PCOS患者循环免疫标志物水平显著降低(P<.05)。
- 血管内皮生长因子A、血小板衍生生长因子、IL-8、TNF-α、干扰素-γ及多种趋化因子在PCOS中降低,独立于种族。
- 仅IL-18和C-X-C motif趋化因子配体16在Black与White女性间有统计学显著差异。
关键数值与推荐
- 主要结局为空腹卵泡期血浆CRP和96种循环免疫标志物,采用Milliplex Luminex xMAP assay测定。
- PCOS患者多种免疫标志物降低的显著性阈值为P<.05。
临床怎么用
- 临床解读PCOS免疫状态时应考虑免疫失调而非单纯慢性炎症。
- 非肥胖PCOS患者可能存在免疫抑制和血管生成信号受损,需个体化评估。
- 目前发现尚不足以指导临床实践,需进一步验证。
局限性
- 未纳入代谢指标,无法充分评估代谢因素对免疫标志物的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Polycystic ovary syndrome (PCOS) is a common endocrine disorder often associated with chronic inflammation, but comprehensive characterization of immune markers across diverse patient populations is lacking. OBJECTIVE: To determine whether PCOS exhibits a profile of chronic inflammation or immune dysregulation when analyzed across a diverse patient population. DESIGN: Retrospective cross-sectional study of samples collected between 1987 and 2010 as part of the Androgen Excess Biorepository. SETTING: Reproductive endocrinology clinics at the University of Alabama at Birmingham in Birmingham, Alabama, and Cedars-Sinai Medical Center in Los Angeles, California, where women and adolescents presented for evaluation of androgen excess. PATIENTS: Forty premenopausal women (20 with PCOS, 20 controls) aged 18 to 45 years, categorized by race (Black and White) and PCOS diagnosis. Participants were race, age, and body mass index matched. MAIN OUTCOME MEASURES: Fasted follicular phase plasma concentrations of C-reactive protein and 96 circulating immune markers, including interleukin (IL)-6, tumor necrosis factor-α (TNF-α), and IL-18, measured using a Milliplex Luminex xMAP assay. RESULTS: PCOS patients showed significantly lower levels of circulating immune markers (P < .05). Growth factors (vascular endothelial growth factor A, platelet-derived growth factor), proinflammatory cytokines (IL-8, TNF-α, interferon-γ), and several chemokines were reduced in PCOS patients, independent of race. Only IL-18 and C-X-C motif chemokine ligand 16 showed statistically significant differences between Black and White women. CONCLUSION: This study challenges the prevailing notion of PCOS as a disorder of chronic low-grade inflammation, suggesting instead that immune suppression and impaired angiogenic signaling may be factors in PCOS pathophysiology, especially in nonobese patients. Further research with larger sample sizes and inclusion of metabolic metrics is needed to confirm these findings before they can be applied in clinical practice.
引用
- Pacheco-Sanchez G, Herrera R, Pisarska MD, et al. Multiracial Cytokine Profiling Reveals Immune Dysregulation not Chronic Inflammation in Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2026. PMID: 40976583. doi:10.1210/clinem/dgaf524
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。